{"database": "lobbying", "table": "lobbying_activities", "rows": [[1667638, "a171e1b3-13d4-44b8-b13d-e4e1948bdffe", "Q1", "BROWN RUDNICK LLP", 287895, "APOTEX CORPORATION", 2015, "first_quarter", "HCR", "Implementation of the Biologics Price Competition and Innovation Act (BPCIA); House 21st Century Cures Act Discussion Draft", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2015-04-17T13:56:58.747000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1667638"], "units": {}, "query_ms": 0.38701295852661133, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}